UBE2K Facilitates Erlotinib Resistance and Induces Epithelial Mesenchymal Transition in Osteosarcoma Cancer Stem-Like Cells via Activating the mTOR Signaling
UBE2K facilitated the erlotinib resistance and induced EMT in OSCs via regulating the mTOR signaling.
Authors
- Qi Liu (ORCID: https://orcid.org/0000-0002-3285-7864)
- Dexing Wang (ORCID: https://orcid.org/0009-0004-2914-2675)
- Tian Wang (ORCID: https://orcid.org/0000-0002-6049-006X)
- Lian Zhang (ORCID: https://orcid.org/0000-0001-7757-1539)
- Ping Yang (ORCID: https://orcid.org/0000-0002-4338-568X)
Institutions
- Shanghai Eighth People Hospital (CN)
Publication Details
- Journal
- Pharmacology
- Published
- 2025-03-28
- DOI
- https://doi.org/10.1159/000545370
- Primary Topic
- Histone Deacetylase Inhibitors Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00